{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:27:19Z","timestamp":1788956839647,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Tehran University of Medical Sciences","award":["93-04-160-27889"],"award-info":[{"award-number":["93-04-160-27889"]}]},{"name":"Center for Research of Endemic Parasites of Iran (CREPI) Project","award":["93-04-160-27889"],"award-info":[{"award-number":["93-04-160-27889"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejps.2018.02.018","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T16:52:38Z","timestamp":1518540758000},"page":"138-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Nanoemulsion of atovaquone as a promising approach for treatment of acute and chronic toxoplasmosis"],"prefix":"10.1016","volume":"117","author":[{"given":"Sanaz Jafarpour","family":"Azami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Amani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Keshavarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roqya","family":"Najafi-Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Mohebali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Faramarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeedeh","family":"Shojaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2018.02.018_bb0005","series-title":"Laboratory Animals in Research and Teaching: Ethics, Care, and Methods","author":"Akins","year":"2005"},{"key":"10.1016\/j.ejps.2018.02.018_bb0010","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri1547","article-title":"Host persistence: exploitation of anti-inflammatory pathways by Toxoplasma gondii","volume":"5","author":"Aliberti","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejps.2018.02.018_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1051\/parasite\/2013017","article-title":"Diagnosis of antigenic markers of acute toxoplasmosis by IgG avidity immunoblotting","volume":"20","author":"Ali-Heydari","year":"2013","journal-title":"Parasite"},{"key":"10.1016\/j.ejps.2018.02.018_bb0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1051\/parasite\/2005122171","article-title":"Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil","volume":"12","author":"Alves","year":"2005","journal-title":"Parasite"},{"key":"10.1016\/j.ejps.2018.02.018_bb0025","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/AAC.36.2.326","article-title":"In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii","volume":"36","author":"Araujo","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2018.02.018_bb0030","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1128\/AAC.46.5.1163-1173.2002","article-title":"Antiparasitic agent atovaquone","volume":"46","author":"Baggish","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2018.02.018_bb0035","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0020-7519(00)00053-9","article-title":"Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis","volume":"30","author":"Cauchetier","year":"2000","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejps.2018.02.018_bb0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/bmj.321.7254.142","article-title":"Sources of Toxoplasma infection in pregnant women: European multicentre case-control study commentary: Congenital toxoplasmosis-further thought for food","volume":"321","author":"Cook","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.ejps.2018.02.018_bb0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00436-010-1832-z","article-title":"The effect of essential oils from Thymus broussonetii Boiss on transmission of Toxoplasma gondii cysts in mice","volume":"107","author":"Dahbi","year":"2010","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ejps.2018.02.018_bb0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0001-706X(03)00194-3","article-title":"Efficacy of azithromycin in a murine toxoplasmosis model, employing a Toxoplasma gondii strain from Turkey","volume":"88","author":"Degerli","year":"2003","journal-title":"Acta Trop."},{"key":"10.1016\/j.ejps.2018.02.018_bb0055","first-page":"111","article-title":"An ultrastructural study of the effect of treatment with atovaquone in brains of mice chronically infected with the ME49 strain of Toxoplasma gondii","volume":"75","author":"Ferguson","year":"1994","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.ejps.2018.02.018_bb0060","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJM199305273282103","article-title":"Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS","volume":"328","author":"Hughes","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ejps.2018.02.018_bb0065","first-page":"123","article-title":"Nanoemulsion: an advanced mode of drug delivery system","volume":"3","author":"Jaiswal","year":"2015","journal-title":"Biotech"},{"key":"10.1016\/j.ejps.2018.02.018_bb0070","doi-asserted-by":"crossref","first-page":"1806S","DOI":"10.3945\/jn.109.106864","article-title":"Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products","volume":"139","author":"Kaur","year":"2009","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejps.2018.02.018_bb0075","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ijpara.2003.12.009","article-title":"Toxoplasma gondii: the model apicomplexan","volume":"34","author":"Kim","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejps.2018.02.018_bb0080","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01.inf.0000202070.59190.9a","article-title":"Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretinitis","volume":"25","author":"McLeod","year":"2006","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.ejps.2018.02.018_bb0085","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2018.02.018_bb0090","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1590\/S0036-46652013000100012","article-title":"Antiretroviral activity of protease inhibitors against Toxoplasma gondii","volume":"55","author":"Monzote","year":"2013","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.ejps.2018.02.018_bb0095","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.4049\/jimmunol.167.8.4574","article-title":"Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines","volume":"167","author":"Mordue","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2018.02.018_bb0100","first-page":"36","article-title":"Solubility enhancement technique for an anti-malarial drug","volume":"6","author":"Pentewar","year":"2015","journal-title":"Der Pharmacia Sinica"},{"key":"10.1016\/j.ejps.2018.02.018_bb0105","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/AAC.45.6.1771-1779.2001","article-title":"Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosis","volume":"45","author":"Sch\u00f6ler","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2018.02.018_bb0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3347\/kjp.2012.50.3.199","article-title":"Real-Time RT-PCR on SAG1 and BAG1 gene expression during stage conversion in immunosuppressed mice infected with Toxoplasma gondii, Tehran Strain","volume":"50","author":"Selseleh","year":"2012","journal-title":"The Korean J. Parasitol."},{"key":"10.1016\/j.ejps.2018.02.018_bb0115","series-title":"Goodman's Gilman's The Pharmacological Basis of Therapeutic","first-page":"1021","article-title":"Chemotherapy of protozoal infections: malaria","volume":"vol. 11","author":"Shapiro","year":"2006"},{"key":"10.1016\/j.ejps.2018.02.018_bb0120","first-page":"37","article-title":"Preparation and optimization of nanoemulsions for targeting drug delivery","volume":"5","author":"Sharma","year":"2013","journal-title":"International Journal of Drug Development and Research"},{"key":"10.1016\/j.ejps.2018.02.018_bb0125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/10611861003733995","article-title":"SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood\u2013brain barriers","volume":"19","author":"Shubar","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejps.2018.02.018_bb0130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2007.06.035","article-title":"Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine","volume":"347","author":"Singh","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.02.018_bb0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","article-title":"Nanoemulsion: concepts, development and applications in drug delivery","volume":"252","author":"Singh","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.02.018_bb0140","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1051\/parasite\/1998053223","article-title":"Assessment of the activity of atovaquone-loaded nanocapsules in the treatment of acute and chronic murine toxoplasmosis","volume":"5","author":"Sordet","year":"1998","journal-title":"Parasite"},{"key":"10.1016\/j.ejps.2018.02.018_bb0145","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.4049\/jimmunol.173.5.3329","article-title":"Coinfection modulates inflammatory responses and clinical outcome of Helicobacter felis and Toxoplasma gondii infections","volume":"173","author":"Stoicov","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejps.2018.02.018_bb0150","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.1128\/AEM.00193-11","article-title":"Grape seed extract for control of human enteric viruses","volume":"77","author":"Su","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.ejps.2018.02.018_bb0155","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/0020-7519(95)00066-B","article-title":"Interconnection between organellar functions, development and drug resistance in the protozoan parasite, Toxoplasma gondii","volume":"25","author":"Tomavo","year":"1995","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejps.2018.02.018_bb0160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1593\/neo.91718","article-title":"Dietary feeding of grape seed extract prevents intestinal tumorigenesis in APCmin\/+ mice","volume":"12","author":"Velmurugan","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejps.2018.02.018_bb0165","first-page":"68","article-title":"Development and validation of stability-indicating RP-HPLC method for estimation of atovaquone","volume":"4","author":"Viplava","year":"2012","journal-title":"International Journal of Pharmaceutical and Clinical Research"},{"key":"10.1016\/j.ejps.2018.02.018_bb0170","first-page":"223","article-title":"Immunohistochemical study of acute and chronic toxoplasmosis in experimentally infected mice","volume":"38","author":"Waree","year":"2007","journal-title":"Southeast Asian J. Trop. Med. Public Health"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718300952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718300952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T18:49:53Z","timestamp":1549910993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098718300952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":34,"alternative-id":["S0928098718300952"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.02.018","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoemulsion of atovaquone as a promising approach for treatment of acute and chronic toxoplasmosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}